Having discovered how a lowly, single-celled fungus regulates its version of cholesterol, Johns Hopkins researchers are gaining new insight about the target and action of cholesterol-lowering drugs taken daily by millions of people to stave off heart attacks and strokes. Their work appears in the December issue of Cell Metabolism. In humans, statin drugs inhibit an enzyme, HMG-CoA reductase, to lower blood cholesterol.
This entry was posted
on Wednesday, December 3rd, 2008 at 2:00 pm and is filed under Cholesterol.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
